Frailty and outcomes after bispecific T-cell engager therapy for patients with relapsed/refractory multiple myeloma Meeting Abstract


Authors: Adegbite, B. O.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hassoun, H.; Maclachlan, K. H.; Shah, U. A.; Hultcrantz, M.; Hamadeh, I. S.; Giralt, S.; Mailankody, S.; Usmani, S. Z.; Hashmi, H.
Abstract Title: Frailty and outcomes after bispecific T-cell engager therapy for patients with relapsed/refractory multiple myeloma
Meeting Title: 66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 144
Issue: Suppl. 1
Meeting Dates: 2024 Dec 7-10
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2024-11-05
Start Page: 4735
End Page: 4736
Language: English
ACCESSION: WOS:001416739600039
DOI: 10.1182/blood-2024-201824
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1053 Giralt
  2. Hani Hassoun
    329 Hassoun
  3. Heather Jolie Landau
    419 Landau
  4. Alexander Meyer Lesokhin
    363 Lesokhin
  5. David Chung
    240 Chung
  6. Michael Scordo
    367 Scordo
  7. Neha Sanat Korde
    226 Korde
  8. Gunjan Lalitchandra Shah
    419 Shah
  9. Urvi A Shah
    187 Shah
  10. Carlyn Rose Tan
    130 Tan
  11. Saad Zafar Usmani
    297 Usmani
  12. Issam S. Hamadeh
    22 Hamadeh
  13. Sridevi Rajeeve
    34 Rajeeve
  14. Eric Jurgens
    14 Jurgens
  15. Hamza Hashmi
    42 Hashmi
  16. Kevin Charles Miller
    10 Miller